3DHEALS’ ecosystem is closely associated with academia, startups, and industries. Concurrently with annual MIT Short Course on Additive Manufacturing, this will be an event full of discovery, networking, and education on 3D printing and bioprinting with a healthcare focus in the mecca of medicine, the city of Boston. Speaker and agenda will be updated soon.
We want to thank GE and GE Ventures for being able to host this event at the GE Boston HQ and its generous sponsorship for light refreshment and drinks.
6:30-7:00 Networking + Registration
7:00-7:10 Sponsors Introduction – Jessica Zeaske (GE Ventures)
7:10-7:15 Jenny Chen and Jess Charlap (3DHEALS)
7:15-7:25 Dr. Albert Woo
7:25-7:30 Q & A
7:30-7:40 Derek Morris (United Therapeutics)
7:40-7:45 Q &A
7:45-7:55 Gideon Balloch (Formlabs)
7:55-8:05 Q & A
8:05-8:15 Gray Chynoweth (ARMI)
8:20-8:45 Panel and QA
8:45 -9:30 Networking and Wrapup
Jenny Chen, MD
Jenny Chen is trained as a neuroradiologist, founder/CEO of 3DHEALS, a company focusing on curating healthcare 3D printing ecosystem. Her main interests include medical education, 3D printing in the healthcare sector, and artificial intelligence. She is also a currnt adjunct clinical faculty in the radiology department at Stanford Healthcare.
Albert Woo, MD
Albert S. Woo, MD, FACS is a board-certified plastic and reconstructive surgeon who specializes in the treatment of cleft and craniofacial anomalies. This work has led to a particular interest in three dimensional imaging and printing of complex surgical models. He is an Associate Professor of Surgery, Pediatrics and Neurosurgery at The Warren Alpert Medical School of Brown University and serves as the Chief of the Division of Pediatric Plastic Surgery, Director of the Cleft and Craniofacial Center at Hasbro Children’s Hospital, and Director of the new Lifespan 3D Printing Laboratory.
Besides medical 3D printing, Dr. Woo’s clinical interests include the surgical treatment of patients with craniosynostosis, complex and syndromic craniofacial abnormalities, and cleft deformities. In particular, he is internationally recognized as an expert in cleft palate repair, after having developed a new surgical technique for this procedure. He is also a nationally recognized for his expertise in Endoscopic Craniosynostosis Surgery, with numerous papers and national presentations on the subject. With more than 60 peer-reviewed publications, numerous chapters and a book, Dr. Woo remains committed not only to clinical excellence but also to advancing research in the treatment of craniofacial anomalies.
Dr. Woo currently is a member of numerous societies including the American College of Surgeons, the American Society of Maxillofacial Surgeons, the American Cleft Palate-Craniofacial Association, the American Association of Plastic Surgeons, and the American Society of Plastic Surgeons. He is the recipient of numerous awards, including recognition by Best Doctors in America since 2011 and Castle Connolly’s Top Doctors.
Jessica Zeaske, PhD, MBA
Jessica A. Zeaske, PhD, MBA, serves as Director of Healthcare Investments at GE Ventures in Boston, MA. At GE Ventures, Jessica focuses on Health IT, IT-enabled Health Services, and Non-Invasive Medical Technology investments. Jessica came to GE Ventures from Lemhi Ventures, a fund investing exclusively in health care services and HCIT with over $330M under management based in Minneapolis, Minnesota. At Lemhi, Jessica developed investment hypotheses, sourced deals, ran diligence processes, and served on multiple Boards. Prior to joining Lemhi, Jessica worked on forming and spinning out companies based on University intellectual property at University of Minnesota and Oregon Health & Science University. Jessica began her career writing software for a start-up health care delivery company. She then moved to a merchant bank, Greenspring Advisors, where she wrote numerous business plans, evaluated, launched and invested in data-driven health care start-up companies. Jessica received an undergraduate degree with honors from Stanford University, graduated from Johns Hopkins School of Public Health with a Master of Health Science and PhD, and completed her MBA with a focus on Healthcare Administration at Regis University. Jessica is currently on the Board of Apervita and Arcadia, and a Board Observer at CareMerge. She previously served on the Boards of PokitDok, PlanSource, OneHealth, Orasi Medical, and Medication Management Solutions. Jessica stays involved with Stanford University by volunteering in various capacities, coaches early stage companies in the public health sector, and serves as a start-up judge and panelist for multiple health care conferences.
Gray Chynoweth serves as Chief Membership Officer for ARMI | BioFabUSA where he oversees membership development and marketing activities and acts as a catalyst for the emerging bio fabrication ecosystem.
Prior to joining ARMI | BioFabUSA in January of 2018, Gray was an executive at multiple information technology companies. As an early executive at Dyn (acquired by Oracle), Gray helped scale the company from less than 20 to more than 450 employees, raise $50,000,000 in venture capital funding, grow revenue 30x and establish global operations, with offices in the US, the UK, and Australia.
Gray holds a J.D. and M.A. in Public Policy from Duke University and was awarded a B.A. in Political Science from the University of California at Berkley, where he graduated magna cum laude.